ARCHIVES

Congress Passes Biomedical Research Authorization, Regular Appropriations Bill; NCI Gets $1.183 Billion

This article is from The Cancer Letter archive.

Vol. 10 No. 40 | October 19, 1984

Download PDF Visit The Full Archive

Related Articles

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979

Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation

August 29, 2014

NCI FY 1991 Operating Budget Outlined In Chart

December 7, 1990

ASCO Updates Guideline On Antiemetics

June 30, 2006

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

October 14, 2005

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004